Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors

US10968223B2 · kind B2 · utility

Assignee

• PROXIMAGEN, LLC · US

Inventors

• Max Espensen · London, GB
• Lee Patient · Linton, US
• David Michael Evans · Royston, GB
• Iain Simpson · Cambridge, GB
• Edward Savory · Cambourne, GB

Key dates

• Filing date: Jul 20, 2020
• Grant date: Apr 6, 2021
• Expiry date: Jul 20, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C53/18
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A process for the preparation of a compound of formula (Ia) or a pharmaceutically acceptable salt, or N-oxide thereof that includes reacting a compound of formula (IIIa) or (Va) with a compound of formula (IX) to form the compound of formula (Ia)